首页|血管生成素样蛋白3对预测冠心病PCI术后并发心力衰竭的临床价值

血管生成素样蛋白3对预测冠心病PCI术后并发心力衰竭的临床价值

扫码查看
目的 探讨血管生成素样蛋白3(ANGPTL3)对预测冠心病经皮冠状动脉介入(PCI)术后并发心力衰竭(HF)的临床价值。方法 选取2020年1月至2022年1月该院收治的接受PCI术治疗的128例冠心病患者纳入研究,根据术后1年随访期间患者是否并发HF,将其分为合并HF组(41例)和无HF组(87例),另选取30例体检健康者纳入对照组。应用酶联免疫吸附试验法检测并比较各组血清ANGPTL3水平,采用超声心动图测定心功能相关指标[左心室收缩末内径(LVESD)、左心房内径(LAD)、左心室后壁厚度(LVPW)及左室射血分数(LVEF)],应用Pearson相关性分析ANGPTL3与心功能相关指标的相关性,采用受试者操作特征(ROC)曲线分析血清ANGPTL3对预测冠心病PCI术后并发HF的临床价值。结果 3组血清ANGPTL3水平比较,差异有统计学意义(P<O。001)。与对照组比较,合并HF组及无HF组患者血清ANGPTL3水平较高,差异有统计学意义(P<0。001)。与无HF组比较,合并HF组患者血清ANGPTL3水平较高,LVESD、LAD及LVPW测定值较高,而LVEF测定值较低,差异均有统计学意义(P<0。001)。Pearson相关性分析结果显示,血清ANGPTL3表达水平与美国纽约心脏病学会心功能分级及LVESD、LAD、LVPW 均呈正相关(P<0。001),而与LVEF呈负相关(P<0。001)。ROC曲线分析结果显示,血清ANGPTL3预测冠心病PCI术后并发HF的曲线下面积为0。803[95%可信区间0。684~0。935,P<0。001],诊断截断值为41。27 g/L,敏感度为91。32%,特异度为73。29%,约登指数为0。647。结论 ANGPTL3在冠心病合并HF患者血清中表达升高,且其表达水平与患者心功能有关,或将成为冠心病PCI术后并发HF的评价指标。
Clinical value of angiopoietin-like protein 3 in predicting heart failure complicated by PCI in coronary heart disease
Objective To investigate the clinical value of angiopoietin-like protein 3(ANGPTL3)in pre-dicting heart failure(HF)after percutaneous coronary intervention(PCI)in coronary heart disease.Methods A to-tal of 128 patients with coronary heart disease treated with PCI from January 2020 to January 2022 were in-cluded in the study.According to whether the patients were complicated by HF during the one-year follow-up period after surgery,they were divided into the HF group(41 cases)and the HF-free group(87 cases),and 30 healthy patients were selected for the control group.Serum samples were collected from each group,and the serum ANGPTL3 levels of each group were detected and compared by enzyme-linked immuno sorbent assay.Cardiac function related indicators[left ventricular end-diastolic diameter(LVESD),left atrial diameter(LAD),left ventricular posterior wall thickness(LVPW),and left ventricular ejection fraction(LVEF)]were measured by echocardiography.Pearson correlation analysis was used to analyze the correlation between AN-GPTL3 and cardiac function-related indexes,and the ROC curve was used to analyze the clinical value of ser-um ANGPTL3 in predicting HF complicated after PCI in coronary heart disease.Results There was signifi-cant difference in serum ANGPTL3 levels among the three groups(P<0.001).Compared with the control group,the serum levels of ANGPTL3 in the patients with HF and without HF were higher,with statistical significance(P<0.001).Compared with the HF-free group,the serum level of ANGPTL3 in the patients with HF was higher,and the measured values of LVESD,LAD and LVPW were higher,while the measured values of LVEF were lower,and the differences were statistically significant(P<0.001).Pearson correlation analysis showed that the expression level of serum ANGPTL3 was positively correlated with New York Heart Associ-ation cardiac function classification,LVESD,LAD and LVPW(P<0.001),but negatively correlated with LVEF(P<0.001).The ROC curve analysis showed that the area under the curve of serum ANGPTL3 for predicting HF after PCI was 0.803(95%confidence interval 0.684-0.935,P<0.001),the diagnostic cutoff value was 41.27 g/L,the sensitivity was 91.32%,the specificity was 73.29%,and the Youden index was 0.647.Conclusion ANGPTL3 expression in serum of patients with coronary heart disease complicated with HF is increased.Its expression level is related to the patient's cardiac function.It will become an evaluation index for HF complicated by PCI after coronary heart disease surgery.

Angiopoietin-like protein 3Coronary heart diseasePercutaneous coronary interven-tionHeart failureClinical value

张洪

展开 >

重庆市璧山区中医院检验科,重庆 402760

血管生成素样蛋白3 冠心病 经皮冠状动脉介入术 心力衰竭 临床价值

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(13)